AbstractObjectives. It is unknown whether a therapeutic combination of aspirin (ASA) and ticlopidine might effectively decrease activation of hemostasis.Background. Percutaneous transluminal coronary angioplasty (PTCA), rotational atherectomy and stent implantation are procedures that fracture or ablate endothelium and plaque, a situation that activates hemostasis.Methods. In 85 patients undergoing PTCA for a 77.8 ± 1% stenosis, we measured markers of coagulation and platelet activation (thrombin-antithrombin complexes [TAT], prothrombin fragment 1 + 2 [F1+2] serotonin and the presence of circulating activated platelets reacting with monoclonal antibodies against glycoproteins exposed on platelet membranes). Blood samples were drawn from a ...
Platelet activation plays a critical role both in spontaneous coronary artery thrombosis due to athe...
AbstractAspirin is the most widely prescribed agent to reduce the platelet-mediated contributions to...
The effects of the antiaggregant substance ticlopidine and of the anticoagulant acenocoumarol on pat...
AbstractObjectives. It is unknown whether a therapeutic combination of aspirin (ASA) and ticlopidine...
Previous studies indicate that percutaneous transluminal coronary angioplasty (PTCA) is associated w...
AbstractObjectives. This study sought to investigate the contribution of ticlopidine to the inhibiti...
The effects of a premedication of aspirin and ticlopidine combined with an increased use of coronary...
Background In many patients today, elective percu-taneous transluminal coronary angioplasty is follo...
Background—Platelet inhibition at the time of a percutaneous coronary intervention has consistently ...
Background—Abciximab and ticlopidine reduce adverse cardiovascular events after percutaneous translu...
Drugs that dissolve blood clots (thrombolytic agents) and drugs that prevent clot propaga-tion (anti...
BACKGROUND: Platelet activation plays a major role in acute vessel closure after coronary angioplast...
Objective: Coagulation activation markers are significantly elevated in patients with peripheral art...
ObjectiveCoagulation activation markers are significantly elevated in patients with peripheral arter...
Activated platelets and leukocytes have been demonstrated to play a role in the development of stent...
Platelet activation plays a critical role both in spontaneous coronary artery thrombosis due to athe...
AbstractAspirin is the most widely prescribed agent to reduce the platelet-mediated contributions to...
The effects of the antiaggregant substance ticlopidine and of the anticoagulant acenocoumarol on pat...
AbstractObjectives. It is unknown whether a therapeutic combination of aspirin (ASA) and ticlopidine...
Previous studies indicate that percutaneous transluminal coronary angioplasty (PTCA) is associated w...
AbstractObjectives. This study sought to investigate the contribution of ticlopidine to the inhibiti...
The effects of a premedication of aspirin and ticlopidine combined with an increased use of coronary...
Background In many patients today, elective percu-taneous transluminal coronary angioplasty is follo...
Background—Platelet inhibition at the time of a percutaneous coronary intervention has consistently ...
Background—Abciximab and ticlopidine reduce adverse cardiovascular events after percutaneous translu...
Drugs that dissolve blood clots (thrombolytic agents) and drugs that prevent clot propaga-tion (anti...
BACKGROUND: Platelet activation plays a major role in acute vessel closure after coronary angioplast...
Objective: Coagulation activation markers are significantly elevated in patients with peripheral art...
ObjectiveCoagulation activation markers are significantly elevated in patients with peripheral arter...
Activated platelets and leukocytes have been demonstrated to play a role in the development of stent...
Platelet activation plays a critical role both in spontaneous coronary artery thrombosis due to athe...
AbstractAspirin is the most widely prescribed agent to reduce the platelet-mediated contributions to...
The effects of the antiaggregant substance ticlopidine and of the anticoagulant acenocoumarol on pat...